Corcept Therapeutics Incorporated (CORT) Cash Flow: Operating & Free Cash Flow

Corcept Therapeutics Incorporated (CORT) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Corcept Therapeutics Incorporated generated $142.00M of operating cash flow and spent $211.00K on capital expenditures. That left free cash flow of $141.78M, down 27.6% from $195.90M a year earlier, or 18.6% of revenue. It repurchased $245.86M of its own shares.

Corcept Therapeutics Incorporated Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Corcept Therapeutics Incorporated (CORT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	99.65	141.21	106.14	101.42	112.51	106.01	94.18	75.41	129.12
Depreciation & Amortization	1.15	1.34	2.36	3.45	3.07	2.24	2.17	0.24	0.11
Deferred Income Tax	-37.54	-40.19	-29.49	-33.91	4.35	14.09	16.88	14.07	-76.70
Stock Based Compensation	84.50	61.35	48.94	42.44	42.93	33.54	29.31	23.75	13.36
Change in Working Capital	-1.41	45.30	7.86	5.54	-0.06	-5.36	-4.69	3.93	-5.71
Change in Accounts Receivable	-5.81	1.15	-10.07	-17.43	-1.43	-6.27	-2.34	-2.29	-5.44
Change in Inventory	-7.48	0.31	1.27	1.20	3.44	-3.51	-1.04	-7.78	-2.26
Change in Accounts Payable	25.07	-2.25	6.63	13.45	-3.60	3.16	-0.74	-0.39	6.29
Change in Other Working Capital	-18.29	46.09	11.24	1.38	1.52	1.27	-0.57	14.38	-4.30
Other Operating Activities	-41.90	-10.94	-9.13	1.38	5.09	1.45	-1.74	-1.72	0.76
Net Cash from Operating Activities	142.00	198.07	126.68	120.32	167.89	151.97	136.12	115.67	60.94
Investing Activities
Capital Expenditures	-0.21	-2.17	-0.14	-0.41	-0.47	-1.24	-1.09	-0.30	-0.42
Acquisitions	0.00	0.00	0.00	0.00	-136.60	118.03	116.74	0.00	0.00
Purchases of Investments	-319.61	-588.31	-328.75	-355.07	-312.81	-420.11	-299.04	-233.12	-73.04
Sales/Maturities of Investments	389.58	412.88	419.79	241.15	449.40	302.09	182.30	142.66	0.00
Other Investing Activities	0.00	0.00	0.00	0.00	136.60	-118.03	-116.74	-90.47	-73.04
Net Cash from Investing Activities	69.76	-177.60	90.91	-114.33	136.13	-119.26	-117.83	-90.77	-73.46
Financing Activities
Debt Repayment	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-15.13
Common Stock Issued	25.49	9.62	0.00	0.00	0.00	0.00	0.00	0.00	7.18
Common Stock Repurchased	-245.86	-15.66	-145.43	0.00	-295.99	-9.95	-30.98	-23.66	0.00
Other Financing Activities	-72.94	-22.30	-9.11	-21.67	-6.61	22.16	2.33	9.32	7.18
Net Cash from Financing Activities	-220.37	-28.35	-148.72	-17.28	-302.59	12.21	-28.65	-14.34	-7.95
Summary
Effect of Forex Changes on Cash	1.44	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	-7.17	-7.89	69.22	-11.29	1.43	44.92	-10.36	10.56	-20.47
Cash at Beginning of Period	127.67	135.55	66.33	77.62	76.19	31.27	41.63	31.06	51.54
Cash at End of Period	120.50	127.67	135.55	66.33	77.62	76.19	31.27	41.63	31.06
Free Cash Flow	141.79	195.90	126.54	119.91	167.42	150.73	135.03	115.37	60.52
Supplemental Disclosures
Income Taxes Paid	-	60.27	47.60	39.75	9.10	10.86	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Corcept Therapeutics Incorporated Cash Flow

What is Corcept Therapeutics Incorporated's free cash flow?

Corcept Therapeutics Incorporated generated free cash flow of $141.78M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $142.00M minus $211.00K of capital expenditures. That was down 27.6% from $195.90M a year earlier. Free cash flow equaled 18.6% of revenue.

How much does Corcept Therapeutics Incorporated spend on capital expenditures?

Corcept Therapeutics Incorporated spent $211.00K on capital expenditures in fiscal 2025, compared with $2.17M a year earlier. That equals 0.1% of operating cash flow.

Does Corcept Therapeutics Incorporated pay dividends or buy back shares?

Yes. In fiscal 2025 Corcept Therapeutics Incorporated returned $245.86M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition